Variables | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
---|---|---|---|---|
Gender | Female | Mele | Male | Female |
Age (y) | 22 | 30 | 37 | 35 |
BMI (kg/m2) | 18.59 | 29.41 | 20.90 | 25.65 |
Basic PRL (ng/ml) | 94.7 | 197.0 | 200.0 | 109.0 |
PRL (ng/ml) | 1.6 | 26.3 | 35.6 | 15.5 |
LH (IU/L) | 1.60 | 1.22 | 1.50 | 3.43 |
FSH(IU/L) | 7.65 | 4.28 | 3.63 | 2.79 |
E2 (pg/ml) | 40 | 17 | 16 | 147 |
P (ng/ml) | 0.53 | 0.28 | 0.72 | 17.81 |
T (ng/ml) | 0.52 | 2.03 | 2.20 | 0.66 |
Adenoma | Micro | Macro | Micro | Micro |
D-max (mm) | ā | 10.6 | 9 | ā |
Medication | Bromoc | Bromoc | Bromoc | Bromoc |
Duration (m) | 12 | 42 | 6 | 36 |
Total dose(mg) | 1368.75 | 2934.38 | 450 | 2475 |
Max-dose (mg/d) | 6.25 | 3.75 | 2.5 | 5 |
Side effects | ||||
āPhysical symptoms | Non | Vomiting, Dry mouth, Constipation, Memory loss | Non | Fatigue, Asthenia, Nausea, Dizzy, Somnolence |
āPunding | No | No | No | Yes |
āPathological gambling | No | No | No | No |
āCompulsive shopping | Yes | No | No | Yes |
āHypersexuality | No | Yes | Yes | No |
āDepression | Mild | Mild | Minimal | Mild |
āBIS-11 | 72 points positive | 67 points positive | 52 points negative | 76 points positive |